Antidote Treatment - Nerve Agent, Auto-Injector (ATNAA) [2.1 mg atropine and 600mg pralidoxime (2-PAM)]; Convulsant Antidote for Nerve Agent (CANA) [10mg diazepam]; Advanced Anticonvulsant System (AAS) [10mg midazolam]; Rapid Opioid Countermeasure System (ROCs) [10mg naloxone]

¹May be variable due to agent characteristics, exposure dose, individual response variability, PPE worn at time of exposure, and whether antidotes administered.

²May be variable due to agent characteristics, exposure dose, individual response variability, PPE worn at time of exposure, and whether anticholinergics administered.

³ROCS (naloxone) does not have any significant drug interactions with the drugs contained in ATNAA, CANA or AAS.

⁴Depending on the agent and dose there may be convulsions.

⁵If wearing PPE may be diaphoretic.

⁶Reference ATP 4-02.85/MCRP 4-11.1A/NTRP 4-02.22/AFTTP(I) 3-2.69 for nuances of self-aid, buddy aid, combat lifesaver care, or treatment by the combat medic/corpsman/Air Force medic.